Pharmacotherapy for Patent Ductus Arteriosus: Current Options and Outstanding Questions

E-ISSN： 1875-6336|12|2|110-119

ISSN： 1573-3963

Source： Current Pediatric Reviews, Vol.12, Iss.2, 2016-05, pp. : 110-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type B Patent Ductus Arteriosus

By Wong Abdul Shahboden M. Pauzi W. Ibrahim W.

Pediatric Cardiology, Vol. 28, Iss. 1, 2007-02 ,pp. : 74-75

Springer Publishing Company

Access to resources Recommend Favorite

Transcatheter Management of Patent Ductus Arteriosus

By Shim D. Beekman III R.H.

Pediatric Cardiology, Vol. 19, Iss. 1, 1998-01 ,pp. : 67-71

Springer Publishing Company

Access to resources Recommend Favorite

Indomethacin Treatment of Patent Ductus Arteriosus in Premature Infants

By McIntyre John Van Overmeire Bart van den Anker John N.

Paediatric and Perinatal Drug Therapy, Vol. 4, Iss. 3, 2001-06 ,pp. : 85-91

Informa Healthcare

Access to resources Recommend Favorite

Patent Ductus Arteriosus and Respiratory Outcome in Premature Infants

Neonatology, Vol. 88, Iss. 3, 2005-09 ,pp. : 192-201

Karger

Access to resources Recommend Favorite

Patent Ductus Arteriosus: How Aggressive Should We Be?

Neonatology, Vol. 91, Iss. 4, 2007-06 ,pp. : 318-318

Karger

Access to resources Recommend Favorite